Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7VJT

Crystal Structure of Mtb Pks13-TE in complex with inhibitor coumestan derivative 8

Summary for 7VJT
Entry DOI10.2210/pdb7vjt/pdb
DescriptorPolyketide synthase Pks13 (Termination polyketide synthase), 3,8-bis(oxidanyl)-7-(piperidin-1-ylmethyl)-[1]benzofuro[3,2-c]chromen-6-one (3 entities in total)
Functional Keywordstuberculosis, mycobacterium tuberculosis, antibiotic, transferase
Biological sourceMycobacterium tuberculosis
Total number of polymer chains2
Total formula weight65061.03
Authors
Zhang, W.,Wang, S.S.,Yu, L.F. (deposition date: 2021-09-28, release date: 2022-09-28, Last modification date: 2023-11-29)
Primary citationZhang, W.,Lun, S.,Wang, S.S.,Cai, Y.P.,Yang, F.,Tang, J.,Bishai, W.R.,Yu, L.F.
Structure-Based Optimization of Coumestan Derivatives as Polyketide Synthase 13-Thioesterase(Pks13-TE) Inhibitors with Improved hERG Profiles for Mycobacterium tuberculosis Treatment.
J.Med.Chem., 65:13240-13252, 2022
Cited by
PubMed Abstract: Pks13 was identified as a key enzyme involved in the final step of mycolic acid biosynthesis. We previously identified antitubercular coumestans that targeted Pks13-TE, and these compounds exhibited high potency both in vitro and in vivo. However, lead compound presented potential safety concerns because it inhibits the hERG potassium channel in electrophysiology patch-clamp assays (IC = 0.52 μM). By comparing the Pks13-TE-compound complex and the ligand-binding pocket of the hERG ion channel, fluoro-substituted and oxazine-containing coumestans were designed and synthesized. Fluoro-substituted compound and oxazine-containing coumestan showed excellent antitubercular activity against both drug-susceptible and drug-resistant strains (MIC = 0.0039-0.0078 μg/mL) and exhibited limited hERG inhibition (IC ≥ 25 μM). Moreover, exhibited improved metabolic stability relative to parent compound while showing favorable bioavailability in mouse models via serum inhibition titration assays.
PubMed: 36174223
DOI: 10.1021/acs.jmedchem.2c01064
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.94 Å)
Structure validation

251801

PDB entries from 2026-04-08

PDB statisticsPDBj update infoContact PDBjnumon